DHR Health Urology Institute is the region’s first facility with the designation to treat an enlarged prostate.
EDINBURG, Texas– NeoTract announced that Gustavo Villegas, MD, at the DHR Health Urology Institute, has been designated as a UroLift® Center of Excellence.
As the region’s only facility with this designation, the UroLift®Center of Excellence program is designed to highlight urologists who are committed to educating their patients on Benign Prostatic Hyperplasia (BPH) and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.
“Being the only designated physician accredited with UroLift Center of Excellence in the whole region is thrilling,” states Gustavo Villegas, MD, at DHR Health Urology Institute. “The team at the DHR Health Urology Institute is very excited for the new designation as it shows our commitment to the men in the Rio Grande Valley.”
NeoTract recognized that Dr. Villegas, at the DHR Health Urology Institute, achieved a high level of training and experience with the UroLift System. Dr. Villegas, along with the DHR Health team of Urologists, continue to demonstrate their commitment to exemplary care for patients by providing leading patient-focused treatment options.Treatment with the UroLiftSystem is proven to be minimally invasive, and typically a one-time outpatient solution that provides rapid relief and recovery for men suffering from symptoms associated with BPH, also known as an enlarged prostate. The goal of the UroLiftSystem treatment is to relieve symptoms to resume your daily activities with a rapid recovery.
Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life. Medication is often the first-line therapy for an enlarged prostate, but relief can be inadequate and temporary. The standard alternative to medication is surgery that cuts, heats or removes prostate tissue to open the blocked urethra.
“The team members at DHR Health and DHR Health Urology Institute have worked very hard in order to achieve this designation, which is leading the BPH pathway,” states, Dr. Villegas. “Thank you to my team at the Urology Institute and to all of the physicians and advanced practitioners identifying, referring, caring and treating our patients during this pandemic.”
The DHR Health Urology Institute consists of a highly specialized group of urologists and surgeons who provide the most cutting-edge treatment along with comprehensive care for men, women and children facing a urologic issue. DHR Health Urology Institute offers advanced surgical treatments for incontinence, urinary frequency, urinary retention, testosterone therapy, vasectomies, prostate health, female reconstructive surgery, bladder and kidney stones. The Urology Institute is equipped with in-house radiology and phlebotomy and the home to the only urologic oncology program in the Rio Grande Valley treating all cancers of the urinary tract, including bladder cancer, prostate cancer, and kidney cancer.
About the UroLift® System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.
About DHR Health
DHR Health was founded in 1997 to help over 1.2 million residents resolve limited health care access challenges in a community that lacked public and county hospitals. Today, it is a modern, 500+ bed full-service health system serving over 280,000 patients annually, with 5500+ employees, over 650 physicians and more than 1,400 nurses dedicated to offering a full-continuum of care in over 70 different specialties and subspecialties. DHR Health proudly boasts the best specialty care in the region, a 24/7 functioning level-one trauma center, a robust clinical research division, and developing graduate medical education programs. DHR Health has revolutionized the health care landscape of the Rio Grande Valley and continues to raise the standard of care and transform the health care delivery model for the benefit all local residents. To learn more, visit www.dhrhealth.com.
About DHR Health Urology Institute
The DHR Health Urology Institute is an extensive group of urologists and surgeons who provide the most cutting-edge treatment along with comprehensive care for men, women and children facing a urologic issue. DHR Health Urology Institute offers advanced surgical treatments and focuses on delivering patient-centered care for any condition that affects the kidneys, bladder, prostate, penis, testes or urethra. DHR Health Urology Institute is home to the only urologic oncology program in the Rio Grande Valley, treating all cancers of the urinary tract, including bladder cancer, prostate cancer, and kidney cancer. We collaborate with surgeons, radiation oncologists, and additional specialists to provide patients the latest medical and surgical treatments that result in the best possible outcomes.
To learn more about the UroLift System or the services offered at the DHR Health Urology Institute, please call (956) 362-8767
DHR Health continues to be the premier healthcare provider in South Texas. For more information, please call (956) DOCTORS (362-8677) or visit our website at www.dhrhealth.com.